Skip to main content

Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization?

  • A. JARDINE (a1) (a2), S. J. CONATY (a1) and H. VALLY (a2)

Rates of herpes zoster (HZ) hospitalizations, antiviral prescriptions, and New South Wales emergency-department presentations for age groups <20, 20–39, 40–59 and ⩾60 years were investigated. Trends were analysed using Poisson regression to determine if rates increased following funding of varicella immunization in Australia in November 2005. The regression analysis revealed significantly increasing trends of between 2% and 6% per year in both antiviral prescriptions and emergency-department presentations in all except the <20 years age group. When considered together, the differential changes in rates observed by age group provides preliminary evidence to indicate that HZ incidence is increasing in adults aged >20 years. However, it is not possible to attribute the increasing trends in HZ observed directly to the varicella immunization programme, and continued monitoring and analyses of data for a longer duration, both pre- and post-vaccine introduction, is required.

Corresponding author
*Author for correspondence: Dr A. Jardine, Queensland Health, Development & Information Unit, PO Box 2368, Fortitude Valley, Queensland, 4006, Australia (Email:
Hide All
1.Stein AN, et al. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 2009; 27: 520529.
2.MacIntyre CR, et al. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiology and Infection 2003; 131: 675682.
3.Carapetis JR, et al. The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine 2004; 23: 755761.
4.Brotherton J, et al. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Communicable Diseases Intelligence 2004; 28 (Suppl. 2): vii-S116.
5.Vally H, et al. An outbreak of chickenpox at a child care centre in Western Australia. Costs to the community and implications for vaccination policy. Australian and New Zealand Journal of Public Health 2007; 31: 113119.
6.Chant KG, et al. Varicella-zoster virus infection in Australia. Australian and New Zealand Journal of Public Health 1998; 22: 413418.
7.Nguyen HQ, et al. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New England Journal of Medicine 2005; 352: 450458.
8.Zhou F, et al. Impact of varicella vaccination on health care utilization. Journal of the American Medical Association 2005; 294: 797802.
9.Seward JF, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. Journal of the American Medical Association 2002; 287: 606611.
10.Davis MM, et al. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114: 786792.
11.Jumaan AO, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. Journal of Infectious Diseases 2005; 191: 20022007.
12.Hope-Simpson RE. Nature of herpes zoster – a long-term study and a new hypothesis. Proceedings of the Royal Society of Medicine 1965; 58: 9–20.
13.Brisson M, et al. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20: 25002507.
14.Solomon BA, et al. Lasting immunity to varicella in doctors study (L.I.V.I.D. study). Journal of the American Academy of Dermatology 1998; 38: 763765.
15.Thomas SL, et al. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002; 360: 678682.
16.Brisson M, et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiology and Infection 2000; 125: 651669.
17.Brisson M, et al. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. Journal of Medical Virology 2003; 70(Suppl. 1): S31S37.
18.Schuette MC, Hethcote HW. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bulletin of Mathematical Biology 1999; 61: 10311064.
19.Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiology and Infection 1992; 108: 513528.
20.Mullooly JP, et al. Incidence of herpes zoster, 1997–2002. Epidemiology and Infection 2005; 133: 245253.
21.Yih WK, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003. BMC Public Health 2005; 5: 68.
22.Yawn BP, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clinic Proceedings 2007; 82: 13411349.
23.Patel MS, et al. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infection Control and Hospital Epidemiology 2008; 29: 11571163.
24.Civen R, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatric Infectious Disease Journal 2009; 28: 954959.
25.Gidding HF, et al. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Australian and New Zealand Journal of Public Health 2005; 29: 544551.
26.Gao Z, et al. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiology and Infection 2010; 138: 457468.
27.Oxman MN, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine 2005; 352: 22712284.
28.Cunningham AL, et al. The prevention and management of herpes zoster. Medical Journal of Australia 2008; 188: 171176.
29.Garnett GP, Ferguson NM. Predicting the effect of varicella caccine on subsequent cases of zoster and varicella. Reviews in Medical Virology 1996; 6: 151161.
30.Australian Bureau of Statistics. Population by age and sex, Australian states and territories, JunE 2008. Canberra, 2008.
31.Hull B, et al. Immunisation coverage annual report, 2007. Communicable Diseases Intelligence 2009; 33: 170187.
32.Macartney KK, et al. Varicella vaccination in Australia. Journal of Paediatrics and Child Health 2005; 41: 544552.
33.Gilbert GL, et al. Varicella seroprevalence and vaccine uptake in preschool children. Medical Journal of Australia 2005; 182: 42.
34.Marshall H, et al. Uptake of varicella vaccine – a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine 2005; 23: 53895397.
35.Marshall H, et al. Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine. Journal of Paediatrics and Child Health 2009; 45: 297303.
36.Miller ER, Kelly HA. Varicella infection – evidence for peak activity in summer months. Journal of Infection 2008; 56: 360365.
37.Zak-Prelich M, et al. The role of solar ultraviolet irradiation in zoster. Epidemiology and Infection 2002; 129: 593597.
38.Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infectious Diseases 2004; 4: 2633.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 9
Total number of PDF views: 41 *
Loading metrics...

Abstract views

Total abstract views: 230 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd November 2017. This data will be updated every 24 hours.